|
22 Oct 2025 |
CreditAccess Grameen
|
Consensus Share Price Target
|
1295.70 |
1378.20 |
- |
6.37 |
buy
|
|
|
|
|
08 May 2024
|
CreditAccess Grameen
|
ICICI Direct
|
1295.70
|
1800.00
|
1428.65
(-9.31%)
|
|
Buy
|
|
|
|
|
08 May 2024
|
CreditAccess Grameen
|
Axis Direct
|
1295.70
|
1900.00
|
1428.65
(-9.31%)
|
|
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
08 May 2024
|
CreditAccess Grameen
|
Edelweiss
|
1295.70
|
1800.00
|
1428.65
(-9.31%)
|
|
Buy
|
|
|
Beat on operating metrics; maintained guidance
|
|
08 May 2024
|
CreditAccess Grameen
|
Motilal Oswal
|
1295.70
|
1725.00
|
1428.65
(-9.31%)
|
|
Buy
|
|
|
CreditAccess Grameen (CREDAG) delivered a healthy operational performance in 4QFY24, with 34% YoY growth in PAT to ~INR3.97b (inline). 4QFY24 NII grew ~42% YoY to ~INR8.8b and PPoP grew 36% YoY to ~INR6.8b. FY24 PAT grew ~31% YoY to ~INR5.1b.
|
|
08 May 2024
|
CreditAccess Grameen
|
Emkay
|
1295.70
|
2000.00
|
1428.65
(-9.31%)
|
|
Buy
|
|
|
CredAG continues to report strong GLP growth at 32% YoY/14% QoQ. This, coupled with stable margins and higher other income and partially offset by higher LLP and staff costs (due to one-off provision of Rs260mn towards bonus and ex-gratia), led to an almost in-line PAT at Rs4bn/RoA @5.7% (Emkay PAT: Rs3.9bn).
|
|
20 Mar 2024
|
CreditAccess Grameen
|
ICICI Direct
|
1295.70
|
1700.00
|
1383.15
(-6.32%)
|
|
Buy
|
|
|
|
|
11 Mar 2024
|
CreditAccess Grameen
|
Geojit BNP Paribas
|
1295.70
|
1560.00
|
1322.20
(-2.00%)
|
|
Buy
|
|
|
|
|
20 Jan 2024
|
CreditAccess Grameen
|
Edelweiss
|
1295.70
|
1910.00
|
1667.25
(-22.29%)
|
|
Buy
|
|
|
Strong franchise aligned to its revised upwards guidance
|
|
20 Jan 2024
|
CreditAccess Grameen
|
Axis Direct
|
1295.70
|
1970.00
|
1667.25
(-22.29%)
|
|
Buy
|
|
|
Recommendation: We maintain our BUY recommendation on the stock.
|
|
23 Oct 2023
|
CreditAccess Grameen
|
Axis Direct
|
1295.70
|
1670.00
|
1507.40
(-14.04%)
|
Target met |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|